David Gevorkian, PA-C

David Gevorkian practices at Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health.

David Gevorkian's NPI, 1891125753, was assigned on November 13, 2013. David Gevorkian holds California license 51301.

David Gevorkian's primary practice is Dignity Health - Northridge Hospital Medical Center, at 18300 Roscoe Blvd, Northridge, CA 91325 in Los Angeles County. The practice phone is (818) 885-8500.

David Gevorkian's primary practice is Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health. David Gevorkian is also affiliated with Adventist Health Simi Valley. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links David Gevorkian to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Gevorkian practices, 5 sites in all. Vendor and product names are available with a free account.

Medical is David Gevorkian's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. David Gevorkian is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). David Gevorkian is licensed in California.

CMS data shows 157 Medicare services from David Gevorkian across 3 procedure codes in 2024, for 144 Medicare patients. Medicare paid $13,716 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw David Gevorkian in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 85% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Gevorkian's median patient age at 38, with 55% women.

In 2024, David Gevorkian wrote 253 Medicare Part D claims for 141 patients. 97% of them were for generic drugs. CMS names the drug for 112 of them, across 6 drugs with 11 or more claims each, at $262 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for David Gevorkian for performance year 2024, reported as part of a group. David Gevorkian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to David Gevorkian from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $170.